ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,923.33
-0.80%
US Tech 100
20,661.40
-1.15%
Dow Jones
42,664.19
-0.76%
Brent Oil
74.455
1.13%
Bitcoin
91,981.87
-1.65%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Arcutis Biotherapeutics Inc (ARQT) Quote

Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc (ARQT)

NASDAQ
14.17
-0.13
( -0.91% )
Updated: 11:58:30
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
14.17
Bid
14.17
Ask
14.19
Volume
452,187
13.91 Day's Range 14.6409
3.07 52 Week Range 15.79
Market Cap
1.659B
Previous Close
14.30
Open
14.34
Last Trade
5
@
14.19
Last Trade Time
11:58:32
Financial Volume
$ 6,398,804
VWAP
14.1508
Average Volume (3m)
2,046,961
Shares Outstanding
117,044,591
Dividend Yield
-
PE Ratio
-6.27
Earnings Per Share (EPS)
-2.24
Revenue
59.61M
Net Profit
-262.14M

About Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.arcutis.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Arcutis Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARQT. The last closing price for Arcutis Biotherapeutics was $14.30. Over the last year, Arcutis Biotherapeutics shares have traded in a share price range of $ 3.07 to $ 15.79.

Arcutis Biotherapeutics currently has 117,044,591 shares outstanding. The market capitalization of Arcutis Biotherapeutics is $1.67 billion. Arcutis Biotherapeutics has a price to earnings ratio (PE ratio) of -6.27.

Ask ADVFN Intelligence (AI)

Arcutis Biotherapeutics (ARQT) Options Flow Summary

ARQT Options Flow

Overall Flow

Bullish

Net Premium

43k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

ARQT Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

December 23 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

December 20 2024
Edgar (US Regulatory)

Arcutis Submits ZORYVE® (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis

ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trialsRoflumilast cream was well tolerated and demonstrated a favorable safety and tolerability...

December 16 2024
GlobeNewswire Inc.

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful...

December 06 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Arcutis Announces Promotions on Executive Management Team

Strategic appointments support further growth and position Company for future success WESTLAKE VILLAGE, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

December 03 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

December 02 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.93-6.1589403973515.115.7313.91169404114.80783641CS
41.1791315.7912.07217958013.65240756CS
124.1741.71015.798.03204696111.11334617CS
264.9854.1893362359.1915.797.86215304010.40613128CS
5211347.0031545743.1715.793.0730940888.8784572CS
156-6.32-30.844314299720.4927.41.7618342308.95424813CS
260-8.88-38.524945770123.0540.881.76118712110.05330595CS

ARQT - Frequently Asked Questions (FAQ)

What is the current Arcutis Biotherapeutics share price?
The current share price of Arcutis Biotherapeutics is $ 14.17
How many Arcutis Biotherapeutics shares are in issue?
Arcutis Biotherapeutics has 117,044,591 shares in issue
What is the market cap of Arcutis Biotherapeutics?
The market capitalisation of Arcutis Biotherapeutics is USD 1.67B
What is the 1 year trading range for Arcutis Biotherapeutics share price?
Arcutis Biotherapeutics has traded in the range of $ 3.07 to $ 15.79 during the past year
What is the PE ratio of Arcutis Biotherapeutics?
The price to earnings ratio of Arcutis Biotherapeutics is -6.27
What is the cash to sales ratio of Arcutis Biotherapeutics?
The cash to sales ratio of Arcutis Biotherapeutics is 27.59
What is the reporting currency for Arcutis Biotherapeutics?
Arcutis Biotherapeutics reports financial results in USD
What is the latest annual turnover for Arcutis Biotherapeutics?
The latest annual turnover of Arcutis Biotherapeutics is USD 59.61M
What is the latest annual profit for Arcutis Biotherapeutics?
The latest annual profit of Arcutis Biotherapeutics is USD -262.14M
What is the registered address of Arcutis Biotherapeutics?
The registered address for Arcutis Biotherapeutics is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Arcutis Biotherapeutics website address?
The website address for Arcutis Biotherapeutics is www.arcutis.com
Which industry sector does Arcutis Biotherapeutics operate in?
Arcutis Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXUNXU Inc
$ 1.4301
(487.55%)
385.81M
WATTEnergous Corporation
$ 1.605
(290.32%)
159.58M
INTZIntrusion Inc
$ 5.78
(167.59%)
109.65M
CYNCYNGN Inc
$ 1.2697
(102.21%)
57.71M
HOLOMicroCloud Hologram Inc
$ 4.47
(86.25%)
87.54M
ABPAbpro Holdings Inc
$ 2.1699
(-51.67%)
1.32M
TRAWTraws Pharma Inc
$ 7.595
(-43.41%)
879.38k
LITMSnow Lake Resources Ltd
$ 1.0894
(-31.91%)
43.49M
LGHLWLion Group Holding Ltd
$ 0.0052
(-25.71%)
54.74k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
$ 66.81
(-24.48%)
8.74k
NXUNXU Inc
$ 1.4494
(495.48%)
382.52M
VINCVincerx Inc
$ 0.35
(80.41%)
290.62M
XTIAXTI Aerospace Inc
$ 0.03995
(1.14%)
164.99M
WATTEnergous Corporation
$ 1.61
(291.54%)
158.84M
SMXSMX Security Matters Public Company
$ 0.6311
(78.48%)
111.03M

ARQT Discussion

View Posts
52172 52172 1 week ago
Keep marching 20's imminent 
👍️0
Monksdream Monksdream 4 months ago
ARQT under $15
👍️0
52172 52172 4 months ago
Ath’s incoming
👍️0
52172 52172 4 months ago
Put the crackpipe down
👍️0
52172 52172 4 months ago
Wrong we beat big time sucka
👍️0
52172 52172 4 months ago
12 coming
👍️0
Sierra20 Sierra20 5 months ago
$6 coming
👍️0
Sierra20 Sierra20 5 months ago
Earnings missed big time and this tanks hard
👍️0
52172 52172 6 months ago
Not yet need 20’s which will come
👍️ 1
MiamiGent MiamiGent 6 months ago
ARQT $10.82 HOD!
Everybody happy?
👍️0
52172 52172 6 months ago
Some large transactions happening a sign of whats to come
👍️ 1
52172 52172 6 months ago
Gonna close green watch
👍️0
MiamiGent MiamiGent 6 months ago
ARQT The short interest is about 25%
The free trading float is tiny.
Share Price should rise steadily today.
👍️0
MiamiGent MiamiGent 6 months ago
ARQT $10.69 last pre-mkt buy, up .67 from yesterday's close.
Steadily rising, as I expected.

The mkt for this FDA approved medicine (last night) is reportedly multi- billions of dollars.
👍️0
52172 52172 6 months ago
Im hoping!
👍️0
MiamiGent MiamiGent 6 months ago
ARQT Needham Reiterates BUY on Arcutis Biotherapeutics, maintains $18 Price Target

6:28 AM this morning
👍️0
MiamiGent MiamiGent 6 months ago
ARQT That's right. The market for this is reportedly three times larger than the previous approved candidate- and that one grew about 250% last qtr.
AND, Arcutis (ARQT) will roll out this new medicine by the end of THIS MONTH.

I am going to buy this product- I have psoriasis all over, except my face thank God.
👍️0
52172 52172 6 months ago
Real revenue is gonna begin to come in.
👍️0
52172 52172 6 months ago
Headed to 20’s soon enough!
👍️0
MiamiGent MiamiGent 6 months ago
$ARQT HUge short interest, next to no free float and FDA Approval tonight for a BIG MARKET drug.
The boys will run this tomorrow.
👍️0
MiamiGent MiamiGent 6 months ago
$ARQT
Arcutis Biotherapeutics Inc

My guess it'll be $11 by 8PM.
The real fun starts in Pre-Market, tomorrow, And then I think off to the races in Regular Session.
Bullish
👍️0
MiamiGent MiamiGent 6 months ago
$ARQT Tight Bid and ASK now.
Getting serious.
Bid ARCX
10.55 x 10
Ask XNMS
10.59 x 1
Volume
2,437,578
Bullish
👍️0
MiamiGent MiamiGent 6 months ago
$ARQT
Arcutis Biotherapeutics Inc

I told ya!
Currently in AH
Bid XNMS 10.50 x 13
Ask ARCX 10.67 x 20
Volume
2,429,849
Bullish
👍️0
MiamiGent MiamiGent 6 months ago
$ARQT New traders: Look at those big $10.48 buys!
The few that follow are "paint jobs"- shorts trying to paint weakness.
Pay attention to the big buys!
$ARQT
18:07:49 $10.41 5 paint job
18:07:49 $10.35 20 paint job
18:07:45 $10.48 15 paint job
18:07:25 $10.48 7,900 real buy
18:07:25 $10.48 1,500 real buy
18:07:01 $10.3567 30
18:05:44 $10.49 115
18:04:57 $10.49 9,400
18:04:26 $10.4887 110
18:03:38 $10.42 6,212
18:03:38 $10.42 2,200
Bullish
👍️0
MiamiGent MiamiGent 6 months ago
ARQT Arcutis Biotherapeutics' Zoryve Gets US FDA Approval!
👍️0
Sierra20 Sierra20 6 months ago
I hope it will be approved. I think it will be approved. It’s just weird.
👍️0
MiamiGent MiamiGent 6 months ago
You're being unnecessarily doomsdayish, Sierra.

Fact is FDA has not announced re any candidates since July 3rd. There's an American holiday on the 4th (Thursday) and folks often take the next day off to make it a four-day break with only one vacation day used.
Hope the weather is not as hot in Albania or wherever it is you plot your short plays and bashing.
MG
👍️0
Sierra20 Sierra20 6 months ago
CRL more than likely. I knew it. F! This is horrible!!!!
https://investors.arcutis.com/news-releases/news-release-details/arcutis-provides-update-snda-roflumilast-cream-015-atopic/
👍️0
Sierra20 Sierra20 6 months ago
They got CRL. 😔
There’s no other reason for this delay. Back to $5 I think.
👍️0
Sierra20 Sierra20 6 months ago
I think they are talking to fda to figure out what they needed to do to address the fda’s concerns before giving a pr about CRL.
👍️0
MiamiGent MiamiGent 6 months ago
ARQT Only 40 more minutes for FDA to announce today.
One time it did at 11:30 PM and it was a QUADRUPLE!
👍️0
MiamiGent MiamiGent 6 months ago
You must be short. There's no basis for what you are saying.
👍️0
MiamiGent MiamiGent 6 months ago
AQRT I'm in today.
👍️0
Sierra20 Sierra20 6 months ago
CRL coming at 4 pm est. imo.
👍️0
Sierra20 Sierra20 6 months ago
I think CRL coming…
👍️0
Sierra20 Sierra20 6 months ago
Run
👍️0
52172 52172 6 months ago
Havent missed nothing yet!
👍️0
52172 52172 6 months ago
Monday boom!
👍️0
Sierra20 Sierra20 6 months ago
I have the worst luck. I miss all the PDUFA. If they get delayed should not be a problem.
👍️0
Sierra20 Sierra20 6 months ago
Oh no!!!!!
👍️0
Sierra20 Sierra20 6 months ago
CRL? Delayed? What’s going on?
👍️0
Monksdream Monksdream 6 months ago
ARQT under$10
👍️0
52172 52172 6 months ago
No one knows shit approval is imminent
👍️0
Sierra20 Sierra20 6 months ago
Someone knows something sell off started. 😔
👍️0
Sierra20 Sierra20 6 months ago
I hope they didn’t get a CRL. People are selling. Something is going on.
👍️0
52172 52172 6 months ago
408k share buy ah’s nothing else needed to say!
👍️0
52172 52172 6 months ago
20’s imminent mark this post
👍️0
52172 52172 8 months ago
Load the boat easy money
👍️0
52172 52172 8 months ago
Buy opp!
👍️0
52172 52172 8 months ago
ER coming on the 14th might get a bump then data in july
👍️0

Your Recent History

NASDAQ
ARQT
Arcutis Biotherapeutics
NASDAQ
CLXT
Calyxt
BIT
NSCIT59058F0
International Bank for R...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads